Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ripply1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RIPPLY1 mRNA | CTD | PMID:26290441 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ripply1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RIPPLY1 mRNA | CTD | PMID:26377647 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Ripply1 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of RIPPLY1 mRNA | CTD | PMID:30951980 | cadmium atom | multiple interactions | ISO | Ripply1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIPPLY1 mRNA | CTD | PMID:37325564 | cadmium dichloride | multiple interactions | ISO | Ripply1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIPPLY1 mRNA | CTD | PMID:37325564 | diquat | increases expression | ISO | Ripply1 (Mus musculus) | 6480464 | Diquat results in increased expression of RIPPLY1 mRNA | CTD | PMID:36851058 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIPPLY1 mRNA | CTD | PMID:27188386 | epoxiconazole | increases expression | ISO | Ripply1 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of RIPPLY1 mRNA | CTD | PMID:35436446 | hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPPLY1 mRNA | CTD | PMID:17183730 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of RIPPLY1 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIPPLY1 mRNA | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | Ripply1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of RIPPLY1 mRNA | CTD | PMID:37682722 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of RIPPLY1 mRNA | CTD | PMID:24935251 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of RIPPLY1 mRNA | CTD | PMID:28818685 | valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPPLY1 mRNA more ... | CTD | PMID:17183730 and PMID:27188386 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of RIPPLY1 mRNA | CTD | PMID:23179753 and PMID:26272509 | XL147 | multiple interactions | ISO | Ripply1 (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RIPPLY1 mRNA | CTD | PMID:27935865 | |